DK0975334T3 - Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler - Google Patents

Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler

Info

Publication number
DK0975334T3
DK0975334T3 DK98918424T DK98918424T DK0975334T3 DK 0975334 T3 DK0975334 T3 DK 0975334T3 DK 98918424 T DK98918424 T DK 98918424T DK 98918424 T DK98918424 T DK 98918424T DK 0975334 T3 DK0975334 T3 DK 0975334T3
Authority
DK
Denmark
Prior art keywords
long
therapeutic agents
term release
biodegradable microparticles
relates
Prior art date
Application number
DK98918424T
Other languages
English (en)
Inventor
Subodh Shah
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/843,975 external-priority patent/US6020004A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0975334T3 publication Critical patent/DK0975334T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK98918424T 1997-04-17 1998-04-17 Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler DK0975334T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/843,975 US6020004A (en) 1997-04-17 1997-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs
US6166598A 1998-04-16 1998-04-16
PCT/US1998/007856 WO1998046212A1 (en) 1997-04-17 1998-04-17 Biodegradable microparticles for the sustained delivery of therapeutic drugs

Publications (1)

Publication Number Publication Date
DK0975334T3 true DK0975334T3 (da) 2004-01-19

Family

ID=26741350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918424T DK0975334T3 (da) 1997-04-17 1998-04-17 Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler

Country Status (10)

Country Link
EP (1) EP0975334B1 (da)
JP (1) JP2002514215A (da)
AT (1) ATE252375T1 (da)
AU (1) AU7134898A (da)
CA (1) CA2287534C (da)
DE (1) DE69819145T2 (da)
DK (1) DK0975334T3 (da)
ES (1) ES2205481T3 (da)
PT (1) PT975334E (da)
WO (1) WO1998046212A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47445A1 (en) 1993-11-19 1998-04-17 Janssen Pharmaceutica Nv Microencapsulated 3-piperidinyl-substituted1 1 2-benzisoxazoles and 1 2-benzisothiazoles
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
AU1226901A (en) * 1999-10-22 2001-05-08 Amgen, Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
AU773735B2 (en) * 2000-01-14 2004-06-03 Brown University Research Foundation Micronized freeze-dried particles
US7029700B2 (en) 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
WO2002036169A2 (en) 2000-10-31 2002-05-10 Pr Pharmaceuticals, Inc. Methods and compositions for enhanced delivery of bioactive molecules
EP1829529A1 (en) * 2002-05-03 2007-09-05 PR Pharmaceuticals, Inc. Controlled release compositions of estradiol metabolites
EP1507514B1 (en) * 2002-05-03 2007-02-14 PR Pharmaceuticals, Inc. Controlled release compositions of estradiol metabolites
DK2599502T3 (da) 2003-04-11 2017-04-18 Antriabio Inc Fremgangsmåde til fremstilling af stedspecifikke proteinkonjugater
DK1765294T3 (da) 2004-05-12 2008-11-10 Baxter Int Nukleinsyremikrokugler samt deres fremstilling og afgivelse
PT1758558E (pt) 2004-05-12 2013-12-05 Baxter Healthcare Sa Microesferas contendo oligonucleótidos, sua utilização para o fabrico de um medicamento para o tratamento de diabetes do tipo 1
EP1679065A1 (en) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
US7964574B2 (en) 2006-08-04 2011-06-21 Baxter International Inc. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
EP2146691A2 (en) 2007-04-17 2010-01-27 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
EP2271324A2 (en) * 2008-05-06 2011-01-12 Glaxo Group Limited Encapsulation of biologically active agents
EP2299990A1 (de) * 2008-06-09 2011-03-30 Boehringer Ingelheim International GmbH Neue einbettungspartikel für die inhalation
KR20100037389A (ko) * 2008-10-01 2010-04-09 연세대학교 산학협력단 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법
EP3484450A4 (en) * 2016-07-18 2020-04-01 Tissuegen, Inc. METHODS AND COMPOSITIONS FOR MAINTAINING THE CONFORMATION AND STRUCTURAL INTEGRITY OF BIOMOLECULES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
AU4459196A (en) * 1995-01-23 1996-08-14 Takeda Chemical Industries Ltd. Sustained-release preparation and use

Also Published As

Publication number Publication date
HK1022265A1 (en) 2000-08-04
DE69819145D1 (de) 2003-11-27
WO1998046212A1 (en) 1998-10-22
ATE252375T1 (de) 2003-11-15
EP0975334B1 (en) 2003-10-22
JP2002514215A (ja) 2002-05-14
EP0975334A1 (en) 2000-02-02
DE69819145T2 (de) 2004-08-19
CA2287534A1 (en) 1998-10-22
CA2287534C (en) 2004-12-28
ES2205481T3 (es) 2004-05-01
AU7134898A (en) 1998-11-11
PT975334E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
DK0975334T3 (da) Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler
DK0993831T3 (da) Forbindelser og præparater til tilförsel af aktive stoffer
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DK1283700T3 (da) Farmaceutiske sustained release-præparater til parenteral administration af biologisk aktive hydrofile forbindelser
AU7315301A (en) Compounds and compositions for delivering active agents
EP1100522A4 (en) ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
IL140930A0 (en) Compounds and compositions for delivering active agents
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
DK1140018T3 (da) Polyol/olie-suspensioner til vedvarende frigørelse af proteiner
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
MY140724A (en) Novel arylethene-sulfonamides
HRP20000703B1 (hr) Stabilni pripravci koji sadrže levosimendan i alginsku kiselinu
DK1189615T3 (da) Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner
DK0817643T3 (da) Forbindelser og præparater til administration af aktive midler
ATE429905T1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung